Background
Smoking is a cause of many health problems, including cancers, heart and lung diseases. Health professionals (e.g. doctors, nurses, pharmacists, dentists, etc.) may be able to reduce this harm by helping smokers to quit during a clinic visit. However, it may be difficult for health care providers to recognize smokers. They may also feel they cannot deliver good support as they do not have enough time, skills, training, budget or resources. A change within health professionals' wider organization may help to improve their involvement in care to help people to stop smoking, and in turn improve the chances of them quitting smoking. These changes may include introducing a system for asking patients if they smoke and recording smoking status on the patient health records; providing health care providers with training, budget or resources to help them deliver more effective quitting support; identifying a dedicated staff member to provide quitting support; introducing new rules to restrict smoking or support quitting activities; introducing advice to quit smoking into routine care; and paying health workers for delivering cessation support. This review aimed to find out whether implementing these organizational changes improves health professionals' involvement in quit smoking activities, and whether it helps smokers stop smoking. We assessed the following activities by health professionals to evaluate their involvement in quit smoking activities: 1) asking about tobacco use; 2) documenting smoking status on patient health records; 3) advising smokers to quit; 4) counselling to quit; 5) providing medicines to quit smoking; and 6) referring to other centers such as quitlines (a telephone support service for smokers to quit) where smokers can obtain further help. 2 of the 4 studies significantly f avoured the intervention. M ixed ef f ect and low quality evidence preclude drawing conclusions NB. Illustrative com parative risks and relative ef f ects colum ns have been rem oved, as only narrative syntheses were conducted due to the presence of signif icant heterogeneity am ong studies GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our conf idence in the estim ate of ef f ect. M oderate quality: Further research is likely to have an im portant im pact on our conf idence in the estim ate of ef f ect and m ay change the estim ate. Low quality: Further research is very likely to have an im portant im pact on our conf idence in the estim ate of ef f ect and is likely to change the estim ate. Very low quality: We are very uncertain about the estim ate.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]

System change interventions for tobacco control (primary cessation
1 Self -reported abstinence was verif ied only in one study, and one study reported higher dropout rate in one group. 2 High clinical heterogeneity am ong included studies; outcom es are m easured at dif f erent tim e points, and in dif f erent settings.
B A C K G R O U N D Description of the condition
The consequences of tobacco use are well recognized and understood, as are the benefits of smoking cessation (Critchley 2012; Ebbert 2005; Peto 2000; Taylor 2002). Smoking cessation not only leads to significant and immediate health benefits, but also decreases most of the related risks within a few years of quitting (WHO 2011). Even people who quit later in life gain benefit. For example, among smokers who quit at the age of 65 years, men gain two years of life on average and women gain three (Taylor 2002) . Quitting smoking is associated with a 36% reduction in risk of all-cause mortality among people with coronary heart disease, which is significant when compared with other secondary preventive therapies such as lowering cholesterol (Critchley 2012). Given the high prevalence of smoking, even a modest improvement in smoking cessation rates could translate to major health and economic benefits. Addressing tobacco use within a healthcare setting requires clinical, programme, and system-level changes. According to clinical practice guidelines for treating tobacco use and dependence, all healthcare organizations should develop plans to support consistent and effective identification, documentation and treatment of tobacco smokers (Fiore 2008). As a minimum requirement, all healthcare providers should ask the tobacco use status of the people who consult them, should briefly advise all smokers to quit, and refer them to quitline or other smoking cessation services (Revell 2005 
Description of the intervention
"System change smoking cessation interventions describe specific strategies that healthcare administrators, managed care organisations, and purchasers of health plans can implement to treat tobacco dependence" (AHRQ 2012).They involve systematic identification of smokers and subsequent offering of evidence-based cessation treatments (Fiore 2007). Fiore 2007 has suggested six system-level strategies to facilitate treatment of tobacco dependence: 1. Implement a system for identifying smokers and documenting tobacco-use status in every clinic and hospital; 2. Provide education, resources and feedback to promote provider interventions;
3. Dedicate staff to provide smoking cessation treatment and assess its delivery in staff performance evaluations;
4. Promote hospital policies that support and provide smoking cessation services;
5. Provide evidence-based tobacco dependence treatments (both counselling and pharmacotherapy); 6. Reimburse providers for the delivery of effective tobacco dependence treatments and include these services among their defined duties.
How the intervention might work
The barriers to providing effective smoking cessation support include: lack of support from the organization, perceived objections from patients, lack of systems for identifying smokers, lack of staff time and skill, perceived inability to change practices, perceived lack of efficacy of tobacco dependence treatments, and the cost of providing care (Wolfenden 2009). A strategic system change approach may be effective in addressing these multidimensional factors associated with low smoking care provision and may improve the number of people achieving abstinence. Outcomes for chronically-ill people will improve only when healthcare systems reconfigure themselves to address the needs and concerns of their patients (Wagner 1998). Tobacco smoking is a chronic relapsing condition that often requires ongoing medical and behavioural interventions, and is consequently considered a chronic health condition (Hudson 2010). A system-level change may therefore be essential to deal with the issue.
Why it is important to do this review
System change interventions are multicomponent, and may vary significantly in their intensity, content and delivery. It is not clear which types of approach are more effective than others. A summary of this evidence is critical as, to our knowledge, no systematic review assessing the effectiveness of such interventions has yet been published. This review is intended to identify various system change interventions for smoking cessation, across various healthcare settings, and to evaluate the effectiveness of such approaches at both the participant and organizational levels.
O B J E C T I V E S
To assess the effectiveness of system change interventions within healthcare settings, for increasing smoking cessation or the provision of smoking cessation care, or both.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials (RCTs), cluster-RCTs with at least two intervention sites and two comparator sites, and quasi-RCTs. Interrupted time series studies (ITS) are also eligible for inclusion if they have a clearly-defined point in time when the intervention occurred and at least three data points before and three after the intervention.
Types of participants
People who smoke and are receiving care in a healthcare setting; and the staff working in these healthcare settings.
Types of interventions
System change interventions for smoking cessation are policies and practices designed by organizations to integrate the identification of all smokers and the subsequent offering of evidence-based smoking cessation treatments (pharmacological or non-pharmacological, or both) into the routine delivery of health care (Fiore 2007). Thus we include interventions which have been developed for identifying people who smoke, documenting smoking status and providing tobacco dependence treatment in various healthcare settings (primary, secondary or tertiary care). We considered studies using the components of the system change model described in Fiore 2007, detailed in the Description of the intervention section of this review. We did not consider studies focusing only on training health professionals, identification of smokers (electronic health records) or providing smoking cessation counselling, without a system change approach. As identification of all smokers and providing treatment to them are the crucial components of system change smoking cessation interventions, we considered only studies which aimed to identify all smokers accessing the system and to provide treatment. We excluded studies of interventions with research personnel involvement in intervention delivery. We also excluded studies targeting a single type of health professional within the health service (unless the organization included only one health profession, e.g. a pharmacy employing only pharmacists without any pharmacy technicians or pharmacy assistants), as organizationallevel interventions should target most health professionals in the system in order to deliver tobacco cessation interventions at every clinical encounter. Hence the system change intervention should be designed to integrate the provision of smoking cessation services within the routine delivery of health care.
Types of outcome measures
Primary outcomes
Following the standard methodology of the Cochrane Tobacco Addiction Group, the primary outcome was abstinence from smoking at longest follow-up, assessed as point prevalence (defined as prevalence of abstinence during a time window immediately preceding the follow-up) or continued or prolonged abstinence (defined as abstinence between quit day or predetermined grace period and a follow-up time). We used the strictest available criteria to define abstinence, preferring continuous or prolonged abstinence over point prevalence abstinence, and biochemically-validated abstinence over self-reported abstinence. Studies that did not assess smoking cessation were also eligible for inclusion if they reported any secondary outcome and met the other inclusion criteria. We examined and reported the classification of primary and secondary outcomes in each included study.
Secondary outcomes
Secondary outcomes include process outcomes measured as organizational-level outcomes or outcomes of care:
• Organizational-level outcome measures, including the number of smokers identified with smoking status documented and number of health professionals trained or dedicated to providing cessation support.
• Outcomes of care, including the number of smokers counselled, given self-help materials, offered nicotine replacement therapy (NRT) or other pharmacotherapy, nomination of a quit date, referral to specialist smoking cessation services (such as telephone quitline support) or other health professionals, and provision of a follow-up appointment.
Search methods for identification of studies Electronic searches
We searched the following databases:
• 
Searching other resources
We also searched clinical trial registries (the WHO clinical trial registry and the US National Institute of Health (NIH) clinical trial registry) for ongoing studies. We sought additional studies by screening the references of relevant reviews and identified studies (citation tracking). We also used personal bibliographies and communication with experts in the field to identify any other studies.
Data collection and analysis
Selection of studies
DT implemented the search strategy and merged search results using reference management software (EndNote, Thomson Reuters). We reviewed the titles and abstracts of studies for possible inclusion, and subjected those selected to full-text assessment. We linked together multiple reports of the same study. Two authors (DT and JG) independently assessed all the full-text articles retrieved, and included those studies meeting the inclusion criteria in the review. We resolved any discrepancies by discussion with the third author (BB), a content area expert who acted as an arbiter for disagreement about the intervention or content of the study. Another arbiter (MJA), who is an expert in clinical trials and meta-analysis, checked any methodological discrepancies. We noted characteristics of the studies excluded (after full-text assessment), including the reason for exclusion.
Data extraction and management
Two authors (DT and JG) independently extracted data, using a pilot-tested standardized data collection form. We entered the collected data into Review Manager 5 (RevMan). We contacted authors of the studies by email, where data were not available or unclear.
We extracted the following information from each of the selected studies:
• lead and corresponding authors' information;
• date of publication;
• location and setting;
• methods of recruitment and inclusion criteria;
• methods of randomization, allocation concealment and blinding;
• study design, duration and follow-up details;
• characteristics of participants (e.g. age, sex and smoking status);
• specific details of the intervention (type, duration, content, format and delivery of intervention, use of pharmacotherapy, adherence to therapy and information about the providers);
• control group component;
• number of participants in each arm;
• outcome measures and definitions, including any biochemical validation, and time point at which they were measured and reported;
• Results: estimate of effect with confidence interval and subgroup analysis (summary data of intervention and control group were entered separately into RevMan) and missing data;
• funding and declarations of interest for the primary investigators;
• authors' conclusions;
• additional comments and information.
If studies were reported in more than one publication (e.g. different time points of the study), we extracted the data from all publications onto separate data collection forms and combined them. If there was one full journal article and multiple conference abstracts available, we considered only the journal article. We resolved any disagreements in the data collection process by discussion with a third author (MJA).
Assessment of risk of bias in included studies
Two authors (DT and JG) independently assessed the risk of bias in included studies, with any disagreements resolved by discussion and consensus, and by consulting a third author (MJA) where necessary.
We assessed studies with a separate control group (RCTs, clusterRCTs and quasi-RCTs) using the seven standard Cochrane criteria:
• sequence generation;
• allocation concealment;
• blinding of participants and personnel;
• blinding of outcome assessment;
• incomplete outcome data;
• selective outcome reporting;
• other potential bias.
We judged each criterion for bias on a three-point scale 'low risk', 'high risk' and 'unclear risk' (Higgins 2011), and constructed a 'Risk of bias' table.
1. 'Low risk', when there was a low risk of bias across all key domains.
2. 'Unclear risk', when there was an unclear risk of bias in one or more of the key domains.
3. 'High risk', when there was a high risk of bias in one or more of the key domains. For each included study, we provide a summary assessment of risk of bias.
Measures of treatment effect
We present the intervention effect for each outcome descriptively, summmarizing nominal variables using numbers and proportions. Wherever possible, we have produced a risk ratio (quitters in treatment group/total randomised to the treatment group) / (quitters in control group/total randomised to the control group) for the outcome of each individual trial.
Unit of analysis issues
In the case of trials with repeated observations, we considered the longest follow-up for the analysis (Higgins 2011). We assessed all reported secondary outcomes only at a single time point. Although heterogeneity precluded us from performing a metaanalysis for this review, we had considered using adjusted estimates of effect measures for analyses of cluster-randomized trials. Had such data been unavailable, we would have conducted an approximate analysis where the required information could be obtained (Higgins 2011).
Dealing with missing data
We report the number of participants lost to follow-up by group, where available. For the primary outcome, we used an intentionto-treat analysis approach where possible. This assumes that people lost to follow-up continue smoking (West 2005). However, we also extracted and reported the strategies used in each study to deal with missing data for the primary outcome measure, and where adjustments have been made as part of the study analyses we also report the summary statistics directly from the study reports.
Assessment of heterogeneity
We explored heterogeneity visually using tables and forest plots, by comparing the effect sizes of studies grouped according to potential effect modifiers. These included:
1. Type of intervention (e.g. identification of smokers, documentation of smoking status, treatment, training of health professionals, feedback of services, etc.); 2. Intensity of intervention (e.g. counselling, pharmacotherapy, both counselling and pharmacotherapy, duration of intervention, etc.); 3. Type of health professional involved; 4. Setting (primary, secondary and tertiary); 5. Study design (RCTs, cluster-RCTs, quasi-RCTs or ITS studies);
6. Quality of studies. We assessed statistical heterogeneity using the Chi 2 test for homogeneity (with significance defined at the alpha-level of 10%) and quantified using the I 2 statistic (Higgins 2011). We considered pooling the data using a meta-analysis where heterogeneity was less than 50% (Higgins 2011).
Assessment of reporting biases
We did not systematically assess publication bias, because of the limited number of studies included, in accordance with the Cochrane Handbook (Higgins 2011). If sufficient studies are available in future updates, we will assess publication bias using funnel plots.
Data synthesis
We conducted a meta-analysis for the primary outcome measure using a random-effects model. However, due to the presence of significant heterogeneity (I 2 = 78%), we deemed it inappropriate to present pooled effects, and we therefore present a narrative synthesis of the included studies. We report major characteristics and results for each trial.
Subgroup analysis and investigation of heterogeneity
We did not conduct any subgroup analyses, due to the limited number of included studies and the decision not to pool them.
Sensitivity analysis
We did not conduct any sensitivity analyses, due to the limited number of included studies and the decision not to pool them.
'Summary of findings' table
Following standard Cochrane methodology, we created 'Summary of findings' tables. We created one for the primary cessation outcome, and a second for the secondary outcomes. We considered it important to summarize both the primary cessation outcome and the secondary outcomes, because of the two-phase nature of system change interventions, with the intervention potentially influencing health professional behaviour, which can go on to potentially affect the patient-level outcome. Focusing on both sets of outcomes could help to identify why the intervention is successful or not. Also following standard Cochrane methodology, we used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome, and to draw conclusions about the quality of evidence within the text of the review. As it was impossible to carry out statistical analyses, we provide a narrative summary of outcomes in both 'Summary of findings' tables.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies
Results of the search
The database search yielded 9278 titles. We found three additional studies through other sources (handsearching and trial registry searching). After removing duplicates, we screened 7004 titles and abstracts, reviewed 159 full-text articles, and shortlisted 48 studies. Of those, we excluded 39 after thoroughly reviewing the full text, with reasons recorded in the Characteristics of excluded studies table. We found two ongoing studies through the searches (Bonevski 2016 ; Ostroff 2014); we will perform a full eligibility check once the studies are complete. See Figure 1 for an illustration of eligibility decisions.
Included studies
We included studies if the intervention was designed to integrate the identification of smokers and the subsequent offering of evidence-based tobacco dependence treatment into routine care. 
Intervention
We provide a summary of intervention components implemented by each study as an additional table (Table 1) . All included studies used the services of existing staff to provide the intervention. None of the studies incorporated all six system change strategies. and Winickoff 2014 used a specific action sheet attached to medical records to identify smokers. In Patwardhan 2012, dental technicians identified smokers by asking about their tobacco use and documented the status on a form that was then attached to their prescription to notify pharmacists. In Joseph 2004, various strategies were recommended for implementation across intervention sites to improve identification of smokers and documentation of smoking status by health professionals, including the 'smoking as a vital sign' approach, use of an electronic clinical reminders system and adaptation of a note template to include smoking status. Finally, two studies (Cabezas 2011; Gordon 2010) identified smokers either by office staff or by clinicians, who asked about tobacco use, but without reporting the methods of documentation. All included studies provided clinicians with training. The duration of training ranged from 30 minutes to 20 hours. Two studies (Little 2009; Rothemich 2010) provided feedback to the clinicians and practices. Little 2009 derived data from electronic health records on rates of tobacco use assessment, advice, counselling, referral offers and referral acceptances, which were used to deliver feedback, and provided monthly performance feedback at provider, clinic and cross-clinic levels. In Rothemich 2010, feedback was provided by the quitline service at both patient and practice levels. Patient-level feedback included the number of counselling sessions completed by the participant, smoking status at last contact, difficulties in contacting participants and reasons for any unsuccessful enrolment or early termination. Practice-level feedback was provided quarterly and included the volume of referrals and summary data such as readiness to quit, quit attempts and smoking status. None of the studies reported an intervention which involved a 'champion' co-ordinating tobacco dependence services. However, a core implementation group, which included study staff, professional leaders and administrators of each of the intervention clinics, was present in Little 2009 to facilitate the implementation of intervention components. All the studies included provision of cessation advice by clinicians to all identified smokers, except one (Patwardhan 2012) that did not provide cessation advice to those who had already decided to quit smoking. Smokers were instead referred to a specialist quitline service. In the other studies, the provision of pharmacotherapy was co-ordinated from smoking cessation services external to the organization. None of the included studies reported reimbursement to the providers for delivery of smoking cessation care.
Control group
In four studies (Cabezas 2011; Gordon 2010; Little 2009; Winickoff 2014) usual care was the control condition. In Joseph 2004, each control clinic received five copies of the AHCPR smoking cessation guideline (AHCPR 1996) . In Patwardhan 2012, control group pharmacies received an informal presentation on quitline services, quitline cards and enrolment in Fax to Quit (FTQ) services (a free service). In Rothemich 2010, a traditional tobacco use vital sign stamp (only smoking status recorded) was used in control clinics.
Outcomes
Primary outcomes
Four studies (Cabezas 2011; Gordon 2010; Joseph 2004; Winickoff 2014) reported cessation outcomes. All these studies used self-reported cessation, except for Winickoff 2014, which used cotinine-validated abstinence.
Secondary outcomes
All the studies except Cabezas 2011 reported system-level outcomes (process outcomes). One study (Gordon 2010) assessed system-level outcomes only for the intervention participants, and another (Patwardhan 2012) collected system-level outcome data from healthcare providers. Reported system-level outcomes included the number of people asked about tobacco use, number of smokers advised to quit, number of smokers counselled to quit, number of smokers referred to a specialized smoking cessation clinic, and provision of pharmacotherapy.
Excluded studies
We excluded studies if the study design did not meet the criteria for inclusion, if there was substantial involvement of research personnel in the provision of smoking cessation care, or if the intervention targeted a single health professional (or profession in the case of multidisciplinary health services) within the service. We also excluded studies if the intervention targeted a specific population instead of providing support to all smokers attending the clinic. Specific reasons for exclusion can be found in the Characteristics of excluded studies table.
Risk of bias in included studies
We present rhe 'Risk of bias' assessment for included studies in the 'Risk of bias' table, under each individual Characteristics of included studies table. We also present these results in graphical form in Figure 2 and Figure 3 . 
Blinding
Blinding of both participants and personnel (to avoid performance bias) was not possible due to the study design in any of the included studies, except for Patwardhan 2012, where the study personnel were not aware of the existence of two groups and therefore were considered to be effectively blinded. We rated three studies 
Incomplete outcome data
Four studies (Cabezas 2011; Gordon 2010; Joseph 2004; Winickoff 2014) reported cessation outcomes and included follow-up data. In Cabezas 2011, although the dropout rate was high, it was similar in both groups (43.3% in intervention and 44.8% in control), and hence we rated it at low risk of bias. Gordon 2010 reported moderate dropout rates, but the rate was higher in the intervention group (30.7% versus 26.1%; P < 0.01), so we judged this study to be at high risk of bias for this domain. Although not statistically significant, the follow-up rate in Winickoff 2014 was marginally higher in the control group (64.5% versus 72.4%; P = 0.11) and we therefore rated it at high risk of bias. Joseph 2004 did not report dropout rates by group and we therefore considered this to be at unclear risk of bias. We judged three studies (Little 2009; Patwardhan 2012; Rothemich 2010) which reported only system-level outcomes to be at low risk of bias, as there were no follow-ups involved.
Selective reporting
Only Cabezas 2011 had a published protocol and was therefore rated at low risk of bias for this domain. We considered all other studies to be at unclear risk of bias, as there was no means of checking whether selective reporting had taken place.
Other potential sources of bias
Three studies which reported cessation outcomes used unverified self-report data.
Effects of interventions
See: Summary of findings for the main comparison System change interventions for tobacco control; Summary of findings 2 System change interventions for tobacco control See: Summary of findings for the main comparison for a summary of the main comparisons in this review.
Primary outcome
Four studies (Cabezas 2011; Gordon 2010; Joseph 2004; Winickoff 2014) evaluated the effect of a system change intervention on smoking cessation. Of these, two studies (Cabezas 2011; Gordon 2010) found that the quit rate was higher in the system change intervention group than in the control group. In Cabezas 2011, the primary end point, one-year self-reported continuous abstinence at two-year follow-up, was significantly higher in the intervention group than in the control group, at 8.1% (120/1482) versus 5.8% (78/1345). The adjusted odds ratio (OR) reported by the study was 1.5 (95% confidence interval (CI) 1.05 to 2.14).
We calculated the unadjusted intention-to-treat risk ratio (RR) to be 1. 
Secondary outcomes
We provide a summary of secondary outcomes in an additional table (Table 2 ).
Asking about tobacco use
Of the three studies (Joseph 2004; Patwardhan 2012; Winickoff 2014) that evaluated the effect of a system change intervention on identification of smokers, two reported significant improvements in the intervention group. In Patwardhan 2012, 636 people (measured as counts; no denominator) were screened for tobacco use in all experimental-group pharmacies, compared with five in all control-group pharmacies (P < 0.001). Winickoff 2014 also favoured intervention (59.4% versus 32.6% screened; P < 0.001). However, in Joseph 2004, the intervention did not improve the identification of smokers (76.0% versus 74.3% screened; P = 0.71). Tobacco screening was part of standard care for both groups in two studies (Little 2009; Rothemich 2010), with similar screening rates across the intervention and control groups prior to the start of the studies.
Documentation of smoking status
One study (Joseph 2004) reported the effect of the system change intervention on documentation of smoking status. Before intervention, control sites were significantly more likely to document smoking status than intervention sites (63.1% versus 55.7% respectively; P < 0.001). However, the direction of this difference was reversed after the intervention was implemented (60.7% versus 67.0% respectively; P < 0.001).
Advice to quit
Of the three studies (Patwardhan 2012; Rothemich 2010; Winickoff 2014) that evaluated the effect of a system change intervention on the number of smokers advised to quit, two reported significant improvements in the intervention group. In Patwardhan 2012, 25 smokers (measured as counts; no denominator) were advised to quit in the experimental-group pharmacies compared with three in the control-group pharmacies (P < 0.01). Winickoff 2014 also favoured intervention (50.5% versus 26.9%; P < 0.001). However, in Rothemich 2010 the intervention did not improve the rate of advice, with no significant difference in quitting advice across groups (58.2% intervention versus 55.3% control; P = 0.39). In one study (Little 2009), the provision of advice to quit was standard practice for both groups prior to the start of the study and pre-study rates were similar across groups. 
Counselling to quit
Initiation of NRT or other pharmacotherapy
Two studies (Joseph 2004; Winickoff 2014) evaluated the effect of a system change intervention on the prescription of NRT. Winickoff 2014 reported a significant improvement in the intervention group versus control group (18.5% versus 2.4% respectively; P < 0.001). However, Joseph 2004 reported no significant difference between groups (14.7% intervention versus 18.0% control; P = 0.38).
Quitline referral and enrolment
Rates of quitline referral were assessed by three studies (Patwardhan 2012; Rothemich 2010; Winickoff 2014), and all reported significantly higher rates in the intervention arm. In Rothemich 2010 (21.4% intervention versus 8.7% control; P < 0.001) and in Winickoff 2014 (37.2% intervention versus 9.3% control; P < 0.001), a higher proportions of intervention participants were referred to a quitline. In Patwardhan 2012, 240 intervention participants received a quitline card compared to 85 control participants (P = 0.02; measured as counts; no denominator). Two studies which evaluated quitline enrolment also favoured the intervention. In Winickoff 2014, a higher proportion of intervention participants were enrolled in a quitline programme following intervention (4.1% intervention versus 1.1% control; P < 0.01). In Patwardhan 2012, 81 intervention participants were enrolled in a quitline compared to eight in the control group (P < 0.001; measured as counts; no denominator).
Provided self-help materials
One study (Gordon 2010) assessed the rate of receipt of reading materials among intervention participants (66.5% received reading materials), but this was not measured for the control participants, so we can report no between-group comparisons.
A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
System change interventions for tobacco control (secondary outcomes) 2 of the 3 studies signif icantly f avoured the intervention. The low quality of the evidence precludes drawing conclusions
Quitline referral
Proportion of sm okers ref erred to quitline 3006 (3 studies)* ⊕ very low 1, 3 All 3 studies signif icantly f avoured the intervention. However, the low quality of the evidence precludes drawing conclusions
Quitline enrolment
Proportion of sm okers enrolled in quitline 1191 (2 studies)* ⊕ very low 1, 3 Both studies signif icantly f avoured the intervention. However, the low quality of the evidence precludes drawing conclusions
Prescription of NRT or other pharmacotherapy
Proportion of sm okers received NRT prescription 2615 (2 studies)
Of the 2 studies, 1 significantly f avoured the intervention. M ixed ef f ect and low-quality evidence preclude drawing conclusions NB. Illustrative com parative risks and relative ef f ects colum ns have been rem oved, as only narrative syntheses were conducted due to the presence of signif icant heterogeneity am ong studies * We have not included data f rom one study as the data were collected as counts (no denom inator) GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our conf idence in the estim ate of ef f ect. M oderate quality: Further research is likely to have an im portant im pact on our conf idence in the estim ate of ef f ect and m ay change the estim ate. Low quality: Further research is very likely to have an im portant im pact on our conf idence in the estim ate of ef f ect and is likely to change the estim ate. Very low quality: We are very uncertain about the estim ate.
1 Included studies had high risk of detection bias.
2 Large dif f erence in ef f ect size between studies. 3 High clinical heterogeneity am ong included studies; dif f erent settings, providers and intervention.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
D I S C U S S I O N Summary of main results
This review includes seven cluster-RCTs evaluating the effect of system change interventions on cessation or system-level outcomes, or both. The seven studies were heterogeneous for types of settings, interventions, providers and outcome measures. When we attempted meta-analysis this was corroborated by significant statistical heterogeneity, and we therefore do not report pooled effect estimates for any outcomes. On the basis of the available evidence, it is difficult to draw any firm conclusions about the success of system change interventions in changing cessation practice or enhancing quit rates. The evidence was equivocal for the primary outcome of smoking cessation. However, all studies which evaluated our secondary outcomes, such as documentation of smoking status, quitline referrals and enrolment favoured the intervention. Three of the four studies which evaluated the provision of cessation counselling also supported the intervention. Of the three studies which evaluated outcomes such as asking about tobacco use and advising to quit, two favoured the intervention in both cases. The evidence for using NRT as part of a system change intervention was also uncertain (of the two studies, one favoured the intervention and the other did not show any difference between groups). When interpreting the findings of this review, it is important to consider the two-phase nature of the system change intervention: system change interventions directly promote the delivery of smoking cessation services (i.e. process outcomes), which could subsequently lead to improvement in smoking cessation outcomes among smokers. Hence improvement in smoking cessation is the second phase of the intervention effect. This might be one of the reasons that most of the evaluated process outcomes (secondary outcomes) were improved; however, the effect on the cessation outcome remains inconclusive.
Overall completeness and applicability of evidence
The results should be interpreted with caution, for the following reasons: 1. We could include only seven studies in this review, of which only four evaluated the primary outcome and only a few evaluated each of the secondary outcomes; 2. Clinical practice guidelines for treating tobacco use and dependence (AHRQ 2012) recommend implementing all components of the system change approach; however, none of the included studies implemented all the components of the system change intervention; 3. Although all studies included some components of a system change intervention, such as assessment of smoking status, training clinicians and assisting smokers, the intensity and extent varied widely among studies; 4. None reported reimbursing clinicians or dedicating a staff member to the provision of smoking cessation care; 5. Although guidelines (AHRQ 2012) recommend regular education and training of all staff on providing smoking cessation support, none of the included studies provided ongoing education, and the duration of smoking cessation training also varied widely across studies;
6. Only four studies provided pharmacotherapy from the clinic. The majority of studies were conducted in the USA and none was conducted in low-or middle-income countries. Hence, the generalizability of the findings to low-and middle-income countries is unknown.
Quality of the evidence
The quality of evidence for all the outcomes, including the primary outcome, was low or very low, as reported in Summary of findings for the main comparison, so that we can draw no robust conclusions about how useful system change interventions are. There was a high risk of bias in many studies. Four studies evaluated cessation outcomes, but only one had biochemical verification of the self-reported data. There was inconsistency in most of the outcomes evaluated, which is likely to be due to differences in settings, populations, providers and interventions. Effect sizes also differed greatly between studies. We therefore judge that the overall quality of evidence of the included studies was low.
Potential biases in the review process
The search strategy used in this review was carefully developed, and reviewed by experts in the field, including the review group Information Specialist. We conducted a comprehensive search of a large number of databases. One author went through all references identified by the electronic searches, excluding papers that clearly were not eligible, and two authors independently assessed all potentially eligible titles and abstracts against the eligibility criteria to ensure that no important references were missed. We also searched reference lists of included studies. Despite all of this, we cannot rule out the possibility of missing some important studies. There is always a potential risk of publication bias. Unfortunately, because we found few studies for inclusion in this review, we could not systematically assess publication bias.
Agreements and disagreements with other studies or reviews
Various components of the system change approach, such as training health professionals, using electronic health records for identifying smokers, advising and counselling smokers to quit and providing pharmacotherapy have been evaluated separately in other Cochrane Reviews. However, none of them evaluated the effectiveness of a system change approach. Levy 2004 estimated that such strategies could reduce smoking prevalence by 2% to 3.5% at a population level. AHRQ 2012 guidelines also promote the use of a system change approach to address tobacco smoking.
A U T H O R S ' C O N C L U S I O N S
Implications for practice
Our review could not draw any firm conclusions, as only a handful of relatively low-quality studies were available. However, there was some evidence for the effect of system change interventions on secondary outcomes, such as asking about tobacco use, documentation of smoking status, advising to quit, provision of cessation counselling, referral to and enrolment in quitlines.
Implications for research
Despite the potential of a system change approach to address tobacco use, only limited evidence of relatively low quality is currently available. Well-powered cluster-RCTs are essential to fill in this knowledge gap. Future studies should include all the components of a system change approach, as recommended by Fiore 2007, to make up the intervention. As clinicians frequently cite lack of reimbursement as a barrier to providing smoking cessation support (Wolfenden 2009), it is important to include such components in the intervention. It is also important to include both biochemically-validated cessation and system-level outcomes in every study. As yet there is also no evidence for hospital-based system change interventions for inpatient smokers, which is a deficit to be addressed by future research. Controlled trials from low-and middle-income countries are also required to fill the knowledge gap.
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C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Cabezas 2011
Methods
Design 
Participants
• Baseline survey: 4254 participants: 2112 intervention (mean age 64.6 years, 96. 1% men, 22.6% current smokers and 53.8% ex-smokers) and 2142 control (mean age 63.1 years, 95.3% men, 24.6% current smokers and 52.8% ex-smokers).
• Follow-up survey: 575 smokers (280 intervention and 295 control) completed a follow-up survey 1 year later.
• Post-intervention: 1424 participants: 641 intervention (mean age 64.9 years, 95. 8% men, 24.0% current smokers and 48.7% ex-smokers) and 783 control (mean age 63.8 years, 98.0% men, 24.7% current smokers and 50.7% ex-smokers) Low risk "The study sites (n=20) were randomly assigned to the intervention or control group using simple (not stratified or block) randomisation"
Allocation concealment (selection bias) Low risk "The remaining 20 sites were randomised." Presumably randomized all clusters at once
Blinding of participants and personnel (performance bias) All outcomes • Training/resources/feedback: Staff received a 2-hour orientation and training. Brief refresher training was also included after the project began. Resources such as handouts and referral forms were stocked at each facility and identified a semiprivate area for making calls (to an outside smoking cessation clinic for further assistance). Monthly performance feedback at the provider, office and cross-office levels was provided to intervention sites
• Dedicated staff for smoking cessation treatment: A dedicated staff member was not present, but a core implementation group was established that included the project • Training/resources/feedback: All intervention providers attended approximately 3 hours of training; no feedback was provided.
Patwardhan 2012
• Dedicated staff for smoking cessation treatment: Not present • Promote clinic policies that support smoking cessation: Incorporated a special action sheet to capture tobacco use status of the parents of paediatric patients and documented their smoking status in paediatric medical records
• Tobacco dependence treatment: Ask, Assist and refer approach which included motivational messaging, recommendation and possible provision of NRT (nicotine patch or gum), and enrolment in the free quitline service
• Reimbursement to clinicians: Not included 2) Control: Usual care
Outcomes
Biochemically validated parental smoking cessation rates Number of parents asked about tobacco use Number of parents advised and counselled to quit Number of parents prescribed cessation medication Number of parents referred to the state quitline Notes This study was supported the National Institute of Health. One author declares work as an unpaid consultant for a pharmaceutical company. No other disclosures to report
Risk of bias
Bias
Authors' judgement Support for judgement
Random sequence generation (selection bias)
Low risk "A random generator was used to generate a sequence of group assignments within each of the 6 blocks created by combining the 2 strata"
Allocation concealment (selection bias) Low risk "The first 22 practices that responded were enrolled and randomly assigned to intervention or control groups." Presumably randomised all clusters at once Notes This study is a potentially included study.
Ostroff 2014
Trial name or title Dentists United to Extinguish Tobacco (DUET): a study protocol for a cluster randomized, controlled trial for enhancing implementation of clinical practice guidelines for treating tobacco dependence in dental care settings Methods Design: Cluster-randomized clinical trial Setting: 18 dental care clinics in the USA Intervention providers: dentist, dental hygienist, and dental assistants Data collection: patient exit interviews, provider surveys, site observations, chart audits 
Contact information Notes
This study is ongoing and has a published protocol. The arm 3 may be eligible to include in this review if they make sufficient effort to identify all smokers A P P E N D I C E S Appendix 1. MEDLINE search strategy
